| Standard not met | Reason | Action being taken by the Pharmacy | By when | Notification By Pharmacy Improvements Made |
|---|---|---|---|---|
| 1.6 | The pharmacy offers a service where pharmacists can prescribe treatments for minor illnesses and help with weight loss. However, consultation notes don’t contain enough detail to show why certain treatments were prescribed. In addition, the notes aren’t written during or straight after the consultation, which means they might be inaccurate. This makes it difficult for the pharmacy to show that pharmacists are asking all the right questions and giving proper advice to the people using the service. Without good records, it’s harder to prove that patients are getting safe and effective care |
The pharmacy already has an SOP in place which requires that consultation notes are completed immediately after each consultation. To strengthen compliance, the pharmacy plans to reinforce adherence to this SOP through refresher training the prescribing pharmacist. Although a structured consultation form is already in use and completed by patients to capture medical history and allergies, the pharmacy plans to ensure that pharmacists also include detailed prescribing rationale and clinical decision-making notes in the patient record immediately after the consultation. The pharmacy also plans to introduce periodic audits carried out by an external independent pharmacist prescriber to assess the quality and completeness of consultation notes. This in turn will also aid with standard 1.2 (area for improvement) |
26/08/2025 | 13/08/2025 |
| 4.2 | The pharmacy asks for people’s consent to contact their regular healthcare provider when they access the pharmacist led prescribing service. But there is no evidence to demonstrate that the pharmacy follows this up and notifies the person's regular prescriber when a treatment has been supplied. This does not support care continuity and information sharing which would help to reduce risk. |
The pharmacy already shares information with a patient’s GP following treatment, either by email (where available) or by post. However, there is currently no formal system in place to track and evidence this communication. To address this, the pharmacy plans to implement an updated version of the patient record form with additional fields to confirm whether information has been shared with the GP and to capture the date it was shared. A maximum timeframe of 48 hours will be set for completing this communication. Team members will be briefed on this new process to ensure consistent documentation. A copy of the adjusted form, along with an example entry, has been attached as part of this action plan submission. |
26/08/2025 | 13/08/2025 |